Exploring Machine Learning Techniques to Predict the Response to Omalizumab in Chronic Spontaneous Urticaria
Background: Omalizumab is the best treatment for patients with chronic spontaneous urticaria (CSU). Machine learning (ML) approaches can be used to predict response to therapy and the effectiveness of a treatment. No studies are available on the use of ML techniques to predict the response to Omaliz...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI AG
2021-11-01
|
| Sarja: | Diagnostics |
| Aiheet: | |
| Linkit: | https://www.mdpi.com/2075-4418/11/11/2150 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|